Ingrid Øra Selected Research

Ingrid Øra Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 05/2002
9	Neuroblastoma 01/2022 - 07/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 02/2024
2	Glioma (Gliomas) 01/2024 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2011
2	Ganglioneuroma 05/2009 - 04/2008
2	Hypoxia (Hypoxemia) 07/2003 - 05/2002
1	Hyperemia 02/2024
1	Rhabdomyosarcoma 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Diffuse Intrinsic Pontine Glioma 01/2024
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Central Nervous System Neoplasms 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	COVID-19 12/2020
1	Fatigue 04/2020
1	Wilms Tumor (Wilm's Tumor) 08/2016
1	Osteosarcoma (Osteogenic Sarcoma) 08/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 08/2016
1	Clear Cell Sarcoma 02/2015
1	Kidney Neoplasms (Kidney Cancer) 01/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2014
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 09/2013
1	Infections 09/2013
1	Ganglion Cysts (Ganglion) 07/2013
1	Leukemia 04/2013
1	Chromosomal Instability (Chromosome Stability) 04/2011
1	Anaplasia 11/2010
1	Ganglioneuroblastoma 05/2009
1	Acute Promyelocytic Leukemia 05/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 02/2024 - 05/2002
4	Messenger RNA (mRNA)IBA 04/2014 - 05/2009
3	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2013
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2011
2	larotrectinibIBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 02/2019 - 08/2016
2	Arsenic Trioxide (Trisenox)FDA Link 02/2007 - 05/2004
1	CeramidesIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	LeptinIBA 02/2024
1	dipinacoline glutamateIBA 01/2024
1	CateninsIBA 01/2023
1	SynaptophysinIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	nutlin 3IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	abemaciclibIBA 01/2022
1	TropomyosinIBA 01/2022
1	ribociclibIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2015
1	3-Iodobenzylguanidine (Iobenguane)IBA 02/2015
1	EnzymesIBA 09/2013
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 09/2013
1	inhibin BIBA 04/2013
1	MicroRNAs (MicroRNA)IBA 10/2011
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	Ion Channels (Ion Channel)IBA 11/2010
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 05/2009
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 05/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2009
1	beta CateninIBA 04/2008
1	NBPhox proteinIBA 02/2008
1	Aligeron (AS 2)IBA 05/2004
1	Differentiation AntigensIBA 07/2003
1	Oxygen (Dioxygen)IBA 05/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2002
1	endothelial PAS domain-containing protein 1IBA 05/2002

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
2	Aftercare (After-Treatment) 04/2020 - 08/2016
2	Radiotherapy 08/2016 - 04/2013
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Stem Cell Transplantation 09/2013
1	Maintenance Chemotherapy 04/2013